1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 ITALY PATIENT MONITORING MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2023 - 2030, MILLION USD
3 PORTER’S FIVE FORCE MODEL ANALYSIS
3.1 BARGAINING POWER OF SUPPLIERS
3.2 BARGAINING POWER OF BUYERS
3.3 DEGREE OF COMPETITION
3.4 THREAT OF SUBSTITUTE
3.5 THREAT OF NEW ENTRANTS
4 MARKET SHARE ANALYSIS
4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023
5 MARKET DYNAMICS
5.1 GROWTH DRIVERS
5.1.1 DRIVER 1
5.1.2 DRIVER 2
5.1.3 DRIVER 3
5.1.4 DRIVER 4
5.2 CHALLENGES
5.2.1 CHALLENGE 1
5.2.2 CHALLENGE 2
5.2.3 CHALLENGE 3
5.2.4 CHALLENGE 4
5.3 OPPORTUNITIES
5.3.1 OPPORTUNITY 1
5.3.2 OPPORTUNITY 2
6 ITALY PATIENT MONITORING MARKET BY PRODUCT
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES MARKET
6.2.1 MOBILE CARDIAC TELEMETRY MONITORS
6.2.2 ELECTROCARDIOGRAM (ECG) DEVICES
6.2.3 IMPLANTABLE LOOP RECORDERS
6.2.4 EVENT MONITORS
6.2.5 SMART/WEARABLE ECG MONITORS
6.3 BLOOD GLUCOSE MONITORING SYSTEMS MARKET
6.3.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.3.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.4 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET
6.4.1 HEMODYNAMIC MONITORS
6.4.2 BLOOD PRESSURE MONITORS
6.4.3 DISPOSABLES
6.5 MULTI-PARAMETER MONITORING DEVICES MARKET
6.5.1 LOW-ACUITY MONITORING DEVICE
6.5.2 MID-ACUITY MONITORING DEVICES
6.5.3 HIGH-ACUITY MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES MARKET
6.6.1 PULSE OXIMETERS
6.6.2 SPIROMETERS
6.6.3 CAPNOGRAPHS
6.6.4 PEAK FLOW METERS
6.7 TEMPERATURE MONITORING DEVICE MARKET
6.7.1 HANDHELD TEMPERATURE MONITORING DEVICES
6.7.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
6.7.3 WEARABLE CONTINUOUS MONITORING DEVICES
6.7.4 INVASIVE TEMPERATURE MONITORING DEVICES
6.7.5 SMART TEMPERATURE MONITORING DEVICES
6.8 FETAL AND NEONATAL MONITORING DEVICES MARKET
6.8.1 NEONATAL MONITORING DEVICES
6.8.2 FETAL MONITORING DEVICES
6.9 NEUROMONITORING DEVICES MARKET
6.9.1 ELECTROENCEPHALOGRAPH (EEG) MACHINES
6.9.2 ELECTROMYOGRAPHY MACHINES
6.9.3 CEREBRAL OXIMETER
6.9.4 INTRACRANIAL PRESSURE (ICP) MONITORS
6.9.5 MAGNETOENCEPHALOGRAPHY (MEG) MACHINES
6.9.6 TRANSCRANIAL DOPPLER (TCD) MACHINES
6.10 WEIGHT MONITORING DEVICES MARKET
6.10.1 DIGITAL
6.10.2 ANALOG
6.11 OTHERS DEVICES MARKET
7 ITALY PATIENT MONITORING MARKET BY TYPE
7.1 OVERVIEW
7.2 CONVENTIONAL MARKET
7.3 WIRELESS MARKET
8 ITALY PATIENT MONITORING MARKET BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE MARKET
8.3 HOSPITALS AND CLINICS MARKET
8.4 OTHERS MARKET
9 COMPANY PROFILES
9.1 MEDTRONIC PLC
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.4 PRODUCT PORTFOLIO
9.1.5 BUSINESS PERFORMANCE
9.1.6 BUSINESS SEGMENTS
9.1.7 GEOGRAPHIC SEGMENTS
9.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.1.9 PRIMARY MARKET COMPETITORS
9.2 KONINKLIJKE PHILIPS N.V.
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 OPERATING BUSINESS SEGMENTS
9.2.4 PRODUCT PORTFOLIO
9.2.5 BUSINESS PERFORMANCE
9.2.6 BUSINESS SEGMENTS
9.2.7 GEOGRAPHIC SEGMENTS
9.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.2.9 PRIMARY MARKET COMPETITORS
9.3 GE HEALTHCARE
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 OPERATING BUSINESS SEGMENTS
9.3.4 PRODUCT PORTFOLIO
9.3.5 BUSINESS PERFORMANCE
9.3.6 BUSINESS SEGMENTS
9.3.7 GEOGRAPHIC SEGMENTS
9.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.3.9 PRIMARY MARKET COMPETITORS
9.4 SIEMENS HEALTHINEERS
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 OPERATING BUSINESS SEGMENTS
9.4.4 PRODUCT PORTFOLIO
9.4.5 BUSINESS PERFORMANCE
9.4.6 BUSINESS SEGMENTS
9.4.7 GEOGRAPHIC SEGMENTS
9.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.4.9 PRIMARY MARKET COMPETITORS
9.5 NIHON KOHDEN CORPORATION
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 BUSINESS SEGMENTS
9.5.7 GEOGRAPHIC SEGMENTS
9.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.5.9 PRIMARY MARKET COMPETITORS
9.6 ABBOTT LABORATORIES
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 BUSINESS SEGMENTS
9.6.7 GEOGRAPHIC SEGMENTS
9.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.6.9 PRIMARY MARKET COMPETITORS
9.7 MASIMO CORPORATION
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 BUSINESS SEGMENTS
9.7.7 GEOGRAPHIC SEGMENTS
9.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.7.9 PRIMARY MARKET COMPETITORS
9.8 HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 BUSINESS SEGMENTS
9.8.7 GEOGRAPHIC SEGMENTS
9.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.8.9 PRIMARY MARKET COMPETITORS
9.9 BIOTRONIK SE AND CO. KG
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 OPERATING BUSINESS SEGMENTS
9.9.4 PRODUCT PORTFOLIO
9.9.5 BUSINESS PERFORMANCE
9.9.6 BUSINESS SEGMENTS
9.9.7 GEOGRAPHIC SEGMENTS
9.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.9.9 PRIMARY MARKET COMPETITORS
9.10 HONEYWELL INTERNATIONAL, INC.
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 BUSINESS SEGMENTS
9.10.7 GEOGRAPHIC SEGMENTS
9.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
9.10.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. ITALY PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
TABLE 2. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 3. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 4. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 5. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 6. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 7. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 8. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 9. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 11. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 12. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 13. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 14. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 15. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 16. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 17. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 18. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 19. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 20. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 21. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 22. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 23. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 24. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 25. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 26. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 27. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 28. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 29. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 30. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 31. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 32. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 33. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 34. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 35. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 36. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 37. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 38. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 39. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 40. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 41. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 42. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 43. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 44. ITALY PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
TABLE 45. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 46. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 47. ITALY PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
TABLE 48. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 50. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 51. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 52. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 53. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 54. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 55. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 56. MEDTRONIC PLC: KEY STRATERGY
TABLE 57. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 58. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS
TABLE 59. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 60. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 61. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 62. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY
TABLE 63. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 64. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS
TABLE 65. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 66. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 67. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 68. GE HEALTHCARE: KEY STRATERGY
TABLE 69. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 70. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS
TABLE 71. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 72. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 73. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 74. SIEMENS HEALTHINEERS: KEY STRATERGY
TABLE 75. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 76. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 77. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 78. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 79. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 80. NIHON KOHDEN CORPORATION: KEY STRATERGY
TABLE 81. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 82. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS
TABLE 83. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 84. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 85. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 86. ABBOTT LABORATORIES: KEY STRATERGY
TABLE 87. MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 88. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 89. MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 90. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 91. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 92. MASIMO CORPORATION: KEY STRATERGY
TABLE 93. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 94. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 95. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 96. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 97. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 98. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: KEY STRATERGY
TABLE 99. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 100. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 101. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 102. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 103. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 104. BIOTRONIK SE AND CO. KG: KEY STRATERGY
TABLE 105. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 106. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS
TABLE 107. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 108. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 109. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 110. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. ITALY PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
FIGURE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 8. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 9. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 10. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 11. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 12. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 13. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 14. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 15. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 16. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 17. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 18. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 19. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 20. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 21. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 22. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 23. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 24. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 25. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 26. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 27. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 28. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 30. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 31. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 32. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 33. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 34. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 35. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 36. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 37. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 38. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 39. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 40. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 41. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 42. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 43. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 44. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 45. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 46. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 47. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 48. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 49. ITALY PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
FIGURE 50. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 51. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 52. ITALY PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
FIGURE 53. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 55. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 56. MEDTRONIC PLC: NET SALES, (2021-2023)
FIGURE 57. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS
FIGURE 58. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)
FIGURE 59. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS
FIGURE 60. GE HEALTHCARE: NET SALES, (2021-2023)
FIGURE 61. GE HEALTHCARE: PRIMARY MARKET COMPETITORS
FIGURE 62. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)
FIGURE 63. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS
FIGURE 64. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)
FIGURE 65. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 66. ABBOTT LABORATORIES: NET SALES, (2021-2023)
FIGURE 67. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 68. MASIMO CORPORATION: NET SALES, (2021-2023)
FIGURE 69. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 70. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)
FIGURE 71. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS
FIGURE 72. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)
FIGURE 73. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS
FIGURE 74. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)
FIGURE 75. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS